JG
BSX icon

Jefferies Group’s Boston Scientific BSX Stock Holding History

Jefferies Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.42M Hold
62,500
– – 0.02% 542
2022
Q2 		$2.33M Hold
62,500
– – 0.02% 567
2022
Q1 		$2.77M Sell
62,500
-60,400
-49% -$2.62M 0.02% 578
2021
Q4 		$5.22M Buy
122,900
+62,500
+103% +$2.63M 0.03% 441
2021
Q3 		$2.62M Hold
60,400
– – 0.02% 663
2021
Q2 		$2.58M Hold
60,400
– – 0.02% 661
2021
Q1 		$2.33M Buy
60,400
+40,400
+202% +$1.53M 0.02% 622
2020
Q4 		$719K Hold
20,000
– – 0.01% 1031
2020
Q3 		$764K Buy
+20,000
New +$771K 0.01% 873
2020
Q2 		– Sell
-42,300
Closed -$1.38M – 1365
2020
Q1 		$1.38M Sell
42,300
-19,400
-31% -$758K 0.02% 860
2019
Q4 		$2.79M Buy
61,700
+25,300
+70% +$1.06M 0.02% 848
2019
Q3 		$1.48M Sell
36,400
-38,100
-51% -$1.61M 0.01% 1268
2019
Q2 		$3.2M Buy
74,500
+38,100
+105% +$1.47M 0.02% 691
2019
Q1 		$1.4M Sell
36,400
-1,400
-4% -$53.5K 0.01% 1098
2018
Q4 		$1.34M Sell
37,800
-2,000
-5% -$72.5K 0.01% 1019
2018
Q3 		$1.53M Sell
39,800
-58,000
-59% -$2.03M 0.01% 1104
2018
Q2 		$3.2M Buy
97,800
+96,500
+7,423% +$2.91M 0.02% 671
2018
Q1 		$36K Sell
1,300
-4,700
-78% -$128K ﹤0.01% 2138
2017
Q4 		$149K Sell
6,000
-93,200
-94% -$2.57M ﹤0.01% 2281
2017
Q3 		$2.89M Sell
99,200
-31,700
-24% -$875K 0.02% 758
2017
Q2 		$3.63M Buy
130,900
+91,500
+232% +$2.43M 0.02% 675
2017
Q1 		$980K Buy
39,400
+14,100
+56% +$343K 0.01% 1288
2016
Q4 		$547K Buy
25,300
+20,400
+416% +$445K ﹤0.01% 1546
2016
Q3 		$117K Buy
+4,900
New +$117K ﹤0.01% 2020

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Jefferies Group's BSX Position: Q3 2022 in Review

Jefferies Group reduced its Boston Scientific (BSX) stake by 9.4% in Q3 2022, selling an estimated $200K and leaving 47,911 shares worth $1.86M. The position accounts for 0.02% of the portfolio, ranked #635.

Jefferies Group first reported a position in BSX in Q2 2013 and has held it in 36 quarters since. The position peaked at $6.59M in Q4 2017. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Jefferies Group held 47,911 shares of Boston Scientific worth $1.86M as of Q3 2022.
  • Jefferies Group sold 4,998 Boston Scientific shares in Q3 2022, an estimated $200K.
  • Boston Scientific made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #635 holding.
  • Jefferies Group first reported a position in Boston Scientific in Q2 2013 and has held it in 36 quarters since.
  • Jefferies Group's Boston Scientific position peaked at $6.59M in Q4 2017.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.